Stemline Therapeutics Inc (NASDAQ: STML), a biopharmaceutical stock, is our featured top momentum gainer of the day since it gained over 14% in the last two consecutive trading sessions with far more shares changing hands than in a normal session. During the last trading session, STML was among top gainer in the U.S. healthcare sector having gained 39.5% breaking the long term 200-DMA (Daily Moving Average) at $25.08. The stock closed at $30.44 while recording volumes of 1.40 million shares. During the past 5-trading sessions, STML gained 44.3% with average volumes of 458,849 shares. A momentum in share prices is witnessed after STML accumulated over 56% in the past one month with daily average volume of 187,860 shares. The stock has provided a return of over 200% since it went public in January 2013.
Company Description:
Stemline Therapeutics Inc (NASDAQ: STML) provides biopharmaceutical services offering research, discovery, and development of novel compounds that target cancer stem cells.
1-Year Stock Chart:
Source: Bloomberg
